血管造影病变分布对下肢动脉疾病步行治疗效果的影响
三个月后无痛步行距离从173米增至304米(p<0.001),最大步行距离从448米增至627米(p<0.001)。造影病变分布与步行改善无显著关联(PFWD p=0.059,MWD p=0.44),ANGIO评分与步行改善亦无相关性。
要点
- 12周混合步行训练可显著改善间歇性跛行患者的无痛步行距离和最大步行距离。
- 造影病变分布与步行距离改善无显著统计学关联。
- ANGIO评分所代表的病变严重程度与步行改善无相关性。
核心结论
- 步行治疗可显著改善下肢动脉疾病患者的步行能力。
- 在本探索性队列中,造影病变分布或病变严重程度与步行距离改善之间未观察到统计学显著关联。
研究设计与样本
- 干预为12周混合渐进步行计划,每周1次监督下跑台训练加2次家庭步行。
- 基线评估包括踝肱指数、造影影像(CTA或MRA)和功能运动测试,造影病变分布按位置分类,病变严重程度用ANGIO评分分级。
主要发现
- 三个月后无痛步行距离从173米增至304米,增加131米(p<0.001)。
- 最大步行距离从448米增至627米,增加179米(p<0.001)。
- 病变分布与无痛步行距离变化无显著关联(p=0.059),与最大步行距离变化亦无显著差异(p=0.44)。
- ANGIO评分与无痛步行距离改善无相关性(ρ=-0.10,p=0.57),与最大步行距离改善无相关性(ρ=0.10,p=0.56)。
临床怎么用
- 对间歇性跛行患者,12周混合步行训练可作为改善步行能力的治疗选择。
- 造影病变分布和ANGIO评分不宜单独用于预测步行治疗的反应。
局限性
- 总体样本量小,且多个病变分布组内患者数量有限,无法就病变特征对治疗反应的影响得出确切结论。
- 研究为探索性队列,结果应视为假设生成性,需更大规模研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate whether angiographic lesion distribution and disease severity influence outcomes of walking therapy in patients with lower extremity artery disease (LEAD) and intermittent claudication (IC). METHODS: In this prospective, single-center cohort study, patients with IC participated in a 12-week hybrid progressive walking program consisting of one supervised treadmill session and two home-based walking sessions per week. Baseline evaluation included assessment of ankle-brachial index (ABI), angiographic imaging (CTA or MRA), and functional exercise testing. Pain-free walking distance (PFWD) and maximal walking distance (MWD) were assessed using standardized treadmill protocols. Angiographic lesion distribution was classified according to lesion location, while disease severity was graded using the ANGIO score. RESULTS: Thirty-three patients (mean age 69.1 ± 9.4 years, 75.8% male) with available angiographic imaging were included in the present analysis. After three months, PFWD increased from 173 m to 304 m, an increase of 131 m (p < 0.001), and MWD increased from 448 m to 627 m, an increase of 179 m (p < 0.001). Lesion distribution was not significantly associated with changes in PFWD (p = 0.059), and no statistically significant differences were observed for MWD (p = 0.44). Disease severity, expressed by the ANGIO score, was not correlated with walking improvements (ρ = -0.10, p = 0.57 for PFWD; ρ = 0.10, p = 0.56 for MWD). CONCLUSION: Walking therapy significantly improved walking capacity in patients with LEAD. In this exploratory cohort, no statistically significant associations were observed between angiographic lesion distribution or disease severity and improvements in walking distance. However, the small overall sample size and limited number of patients within several lesion distribution groups preclude firm conclusions regarding the influence of lesion characteristics on treatment response. These findings should therefore be considered hypothesis-generating and warrant confirmation in larger studies.
引用
- El Kaddouri R, Colle A, Cornelis N, et al. Impact of Angiographic Lesion Distribution on Walking Therapy Outcomes in Lower Extremity Artery Disease. Ann Vasc Surg. 2026. PMID: 42951184. doi:10.1016/j.avsg.2026.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。